Skip navigation
Agenda

Effective Strategies for Developing a World-Class Ethics and Compliance Programme

November 14-15, 2018
  • London, United Kingdom

Agenda

Want more agenda details? Download the brochure.

DAY ONEWednesday, 14 November, 2018

8:00

Conference Registration and Welcome Refreshments

8:30

Chairperson’s Welcome and Opening Remarks

Nicola Galtieri
Head of Compliance
Boehringer Ingelheim (Italy)

Walking the Fine Line of Partnering with Patients

8:35

Compliance Aspects of Industry-Patient Interactions

Ursula Hohlneicher
Senior Compliance Director
AstraZeneca (Sweden)

9:20

Key Considerations for Building Successful Patient Advisory Boards

Peter Rupprecht
Head of Compliance Global Healthcare Functions, Group Legal & Compliance
Merck KGaA (Germany)

9:50

SANOFI CASE STUDY An End-to-End Analysis of Fair Market Value from Contracting to Disclosure

Nicholas Pimlett
VP, Global head of Healthcare Transparency
Sanofi (USA)

10:20

Ask the Experts Q&A

Peter Rupprecht
Head of Compliance Global Healthcare Functions, Group Legal & Compliance
Merck KGaA (Germany)

Nicholas Pimlett
VP, Global head of Healthcare Transparency
Sanofi (USA)

10:30

Networking and Refreshment Break

Explore the New Frontier in Competition Law and Whistleblower Protection

11:00

An Overview of Competition Law

Mukundan Bharathan
Regional General Counsel — Europe
Dr. Reddy’s Laboratories SA (Switzerland)

11:45

Examine Whistleblower Protection in the EU

Ulf Grundmann
Partner
King & Spalding (Germany)

12:30

Networking Luncheon and Invitation-Only CCO Summit Luncheon

INVITATION-ONLY
Chief Compliance Officer Summit

12:30

CCO Summit Luncheon

13:30

Welcome and Anti-Trust Guideline Reminders

2018 Theme: Compliance as a Contributive Force This summit is designed to encourage an open exchange of ideas and strategies surrounding some of the most critical issues facing heads of compliance across the life sciences industry. The host facilitates discussions surrounding key questions, challenges and issues. Participants benefit from exclusive networking with peers, sharing concerns and acquiring additional best practices for enriching their compliance programmes.

DIALOGUE STARTERS:

I.Global data privacy and data management

II.Transparency’s role in changing the competitive intelligence landscape

III.Quality measures — Are our KPIs powerful enough?

IV.Emerging technologies and trends

V.Building public trust and confidence

*Invited participants hold the title of Chief Compliance Officer, Vice President of Compliance, General Counsel or an equivalent compliance leadership position at a life sciences company (at the time of the conference). Final eligibility approval is at the discretion of CBI.

FACILITATOR:

David Eves
Head of Compliance
Chugai Pharma Europe Ltd (UK)

15:00

Close of CCO Summit

13:30

Six Months into GDPR — Now What Do We Do?

Munish Duvedi
Business Consultant
GCO Consultancy (Netherlands)

14:15

“It’s Just Good Business” — How Transparency Can Bolster Business Strategy

Feline Smeenk
Global Compliance Manager
IQVIA (Netherlands)

15:00

Networking and Refreshment Break

15:30

The Global Transparency Arena: Activities, Insights and Challenges

Rachel Cooper
Director, Pharmaceuticals and Healthcare Programme
Transparency International (UK)

Reinforce and Streamline Global HCP/HCO Interactions

16:15

ABPI & ABHI SPOTLIGHTAn Update on Current MedTech and Pharmaceutical Guidelines for HCP Engagement

Karen Borrer
Head of Corporate Communication
The Association of the British Pharmaceutical Industry (ABPI) (UK)

Andrew Davies
Director, Market Access
The Association of the British Pharmaceutical Industry (ABPI) (UK)

17:00

Establish a Comprehensive Framework for HCP Risk Management

Brian Sharkey
Vice President and Privacy Officer
Porzio Life Sciences, LLC (USA)

Michael O’Connor
Vice President, Compliance Technology
Porzio Life Sciences, LLC (USA)

17:30

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWOThursday, 15 November, 2018

8:00

Morning Refreshments

8:30

Chairperson’s Review of Day One

Nicola Galtieri
Head of Compliance
Boehringer Ingelheim (Italy)

8:45

IFPMA SPOTLIGHTDeep Dive into Evolving International Best Practices

Sofie Melis
Senior Manager, Ethics & Compliance
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) (Switzerland)

9:30

EMERGING MARKETS EXCHANGEAnti-Bribery and Anti-Corruption Risk Hot Spots — Emerging Markets

For global life sciences companies, it is critical to consistently explore and expand into new markets from both a business- and risk-based profile. Gain a quick update on ABAC risks in four major emerging markets from experts in these areas as part of 15-minute lightning presentations.

I. Eastern Europe

Karolina Czernicka-Kuhl
Director, Legal & Compliance DACH, Eastern Europe, Middle East
Vertex Pharmaceuticals (Germany)

II. China and Asia-Pacific

III. Middle East and Africa

İlknur Kehlibar
Associate Director, Healthcare Compliance
Celgene (Turkey)

10:15

Networking and Refreshment Break

10:45

Anti-Bribery and Anti-Corruption Risk Hot Spots — World Comparison

During this follow-up panel discussion, dive into the risk areas that were identified in the Emerging Markets Exchange and compare them to the UK, US and EU (France, Italy and Spain in particular) markets.

MODERATOR:

Mirjam Weisse
Senior Director, Head of Compliance EMEA
Merz Pharma GmBH & Co. (Germany)

PANELISTS:

Karolina Czernicka-Kuhl
Director, Legal & Compliance DACH, Eastern Europe, Middle East
Vertex Pharmaceuticals (Germany)

İlknur Kehlibar
Associate Director, Healthcare Compliance
Celgene (Turkey)

Promoting Ethical Behaviors Internally and with Partners

11:30

FIRESIDE CHATStrengthen Third-Party Compliance from Vetting to Monitoring

MODERATOR:

Mario Prohasky
Principal, EMEA Compliance Consulting Practice Leader
IQVIA (USA)

Q&A WITH:

Mirjam Weisse
Senior Director, Head of Compliance EMEA
Merz Pharma GmBH & Co. (Germany)

Alexandra Wrage
President and Founder
TRACE International (USA)

12:15

Networking Luncheon

13:15

New Approaches to Compliance Assurance

Detlef Geiges
Senior Director Assurance, Global Methodology & Europe & Russia, Eurasia Lead, AstraZeneca Global Sustainability/Compliance
AstraZeneca (Germany)

14:00

Collaborative PresentationEmbedding Compliance into the Business’s DNA at the Local and Global Levels

Maike Bermueller
Senior Legal Counsel, Global Healthcare Compliance Officer
Boehringer Ingelheim (Germany)

Kyriaki Merakli
Group Compliance Officer
Helsinn Group (Switzerland)

14:45

Twitter, Facebook and Everything In-Between —
Structuring Communications in a Risky Environment

Malene Hammerich Abildstrom
Ethics & Compliance Director
Astellas Pharma (Denmark)

15:30

Chair’s Closing Remarks

Nicola Galtieri
Head of Compliance
Boehringer Ingelheim (Italy)

15:35

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONEWednesday, 14 November, 2018

8:00

Conference Registration and Welcome Refreshments

8:30

Chairperson’s Welcome and Opening Remarks

Nicola Galtieri
Head of Compliance
Boehringer Ingelheim (Italy)

Walking the Fine Line of Partnering with Patients

8:35

Compliance Aspects of Industry-Patient Interactions

Ursula Hohlneicher
Senior Compliance Director
AstraZeneca (Sweden)

9:20

Key Considerations for Building Successful Patient Advisory Boards

Peter Rupprecht
Head of Compliance Global Healthcare Functions, Group Legal & Compliance
Merck KGaA (Germany)

9:50

SANOFI CASE STUDY An End-to-End Analysis of Fair Market Value from Contracting to Disclosure

Nicholas Pimlett
VP, Global head of Healthcare Transparency
Sanofi (USA)

10:20

Ask the Experts Q&A

Peter Rupprecht
Head of Compliance Global Healthcare Functions, Group Legal & Compliance
Merck KGaA (Germany)

Nicholas Pimlett
VP, Global head of Healthcare Transparency
Sanofi (USA)

10:30

Networking and Refreshment Break

Explore the New Frontier in Competition Law and Whistleblower Protection

11:00

An Overview of Competition Law

Mukundan Bharathan
Regional General Counsel — Europe
Dr. Reddy’s Laboratories SA (Switzerland)

11:45

Examine Whistleblower Protection in the EU

Ulf Grundmann
Partner
King & Spalding (Germany)

12:30

Networking Luncheon and Invitation-Only CCO Summit Luncheon

INVITATION-ONLY
Chief Compliance Officer Summit

12:30

CCO Summit Luncheon

13:30

Welcome and Anti-Trust Guideline Reminders

2018 Theme: Compliance as a Contributive Force This summit is designed to encourage an open exchange of ideas and strategies surrounding some of the most critical issues facing heads of compliance across the life sciences industry. The host facilitates discussions surrounding key questions, challenges and issues. Participants benefit from exclusive networking with peers, sharing concerns and acquiring additional best practices for enriching their compliance programmes.

DIALOGUE STARTERS:

I.Global data privacy and data management

II.Transparency’s role in changing the competitive intelligence landscape

III.Quality measures — Are our KPIs powerful enough?

IV.Emerging technologies and trends

V.Building public trust and confidence

*Invited participants hold the title of Chief Compliance Officer, Vice President of Compliance, General Counsel or an equivalent compliance leadership position at a life sciences company (at the time of the conference). Final eligibility approval is at the discretion of CBI.

FACILITATOR:

David Eves
Head of Compliance
Chugai Pharma Europe Ltd (UK)

15:00

Close of CCO Summit

13:30

Six Months into GDPR — Now What Do We Do?

Munish Duvedi
Business Consultant
GCO Consultancy (Netherlands)

14:15

“It’s Just Good Business” — How Transparency Can Bolster Business Strategy

Feline Smeenk
Global Compliance Manager
IQVIA (Netherlands)

15:00

Networking and Refreshment Break

15:30

The Global Transparency Arena: Activities, Insights and Challenges

Rachel Cooper
Director, Pharmaceuticals and Healthcare Programme
Transparency International (UK)

Reinforce and Streamline Global HCP/HCO Interactions

16:15

ABPI & ABHI SPOTLIGHTAn Update on Current MedTech and Pharmaceutical Guidelines for HCP Engagement

Karen Borrer
Head of Corporate Communication
The Association of the British Pharmaceutical Industry (ABPI) (UK)

Andrew Davies
Director, Market Access
The Association of the British Pharmaceutical Industry (ABPI) (UK)

17:00

Establish a Comprehensive Framework for HCP Risk Management

Brian Sharkey
Vice President and Privacy Officer
Porzio Life Sciences, LLC (USA)

Michael O’Connor
Vice President, Compliance Technology
Porzio Life Sciences, LLC (USA)

17:30

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWOThursday, 15 November, 2018

8:00

Morning Refreshments

8:30

Chairperson’s Review of Day One

Nicola Galtieri
Head of Compliance
Boehringer Ingelheim (Italy)

8:45

IFPMA SPOTLIGHTDeep Dive into Evolving International Best Practices

Sofie Melis
Senior Manager, Ethics & Compliance
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) (Switzerland)

9:30

EMERGING MARKETS EXCHANGEAnti-Bribery and Anti-Corruption Risk Hot Spots — Emerging Markets

For global life sciences companies, it is critical to consistently explore and expand into new markets from both a business- and risk-based profile. Gain a quick update on ABAC risks in four major emerging markets from experts in these areas as part of 15-minute lightning presentations.

I. Eastern Europe

Karolina Czernicka-Kuhl
Director, Legal & Compliance DACH, Eastern Europe, Middle East
Vertex Pharmaceuticals (Germany)

II. China and Asia-Pacific

III. Middle East and Africa

İlknur Kehlibar
Associate Director, Healthcare Compliance
Celgene (Turkey)

10:15

Networking and Refreshment Break

10:45

Anti-Bribery and Anti-Corruption Risk Hot Spots — World Comparison

During this follow-up panel discussion, dive into the risk areas that were identified in the Emerging Markets Exchange and compare them to the UK, US and EU (France, Italy and Spain in particular) markets.

MODERATOR:

Mirjam Weisse
Senior Director, Head of Compliance EMEA
Merz Pharma GmBH & Co. (Germany)

PANELISTS:

Karolina Czernicka-Kuhl
Director, Legal & Compliance DACH, Eastern Europe, Middle East
Vertex Pharmaceuticals (Germany)

İlknur Kehlibar
Associate Director, Healthcare Compliance
Celgene (Turkey)

Promoting Ethical Behaviors Internally and with Partners

11:30

FIRESIDE CHATStrengthen Third-Party Compliance from Vetting to Monitoring

MODERATOR:

Mario Prohasky
Principal, EMEA Compliance Consulting Practice Leader
IQVIA (USA)

Q&A WITH:

Mirjam Weisse
Senior Director, Head of Compliance EMEA
Merz Pharma GmBH & Co. (Germany)

Alexandra Wrage
President and Founder
TRACE International (USA)

12:15

Networking Luncheon

13:15

New Approaches to Compliance Assurance

Detlef Geiges
Senior Director Assurance, Global Methodology & Europe & Russia, Eurasia Lead, AstraZeneca Global Sustainability/Compliance
AstraZeneca (Germany)

14:00

Collaborative PresentationEmbedding Compliance into the Business’s DNA at the Local and Global Levels

Maike Bermueller
Senior Legal Counsel, Global Healthcare Compliance Officer
Boehringer Ingelheim (Germany)

Kyriaki Merakli
Group Compliance Officer
Helsinn Group (Switzerland)

14:45

Twitter, Facebook and Everything In-Between —
Structuring Communications in a Risky Environment

Malene Hammerich Abildstrom
Ethics & Compliance Director
Astellas Pharma (Denmark)

15:30

Chair’s Closing Remarks

Nicola Galtieri
Head of Compliance
Boehringer Ingelheim (Italy)

15:35

Close of Conference